Thomas Lundback
R&d
Moelndal, O 43183, Sweden
Moelndal, O 43183, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Systematic Application of a Cellular Thermal Shift Assay for Inferring Inhibitor Binding Affinity to 17βHSD13 in a Humanized Liver Homogenate.
Journal: Biochemistry
Published: January 12, 2026
The rise and fall of SARM1 base-exchange inhibitors.
Journal: Communications chemistry
Published: December 19, 2025
Correction to "Closing the Design-Make-Test-Analyze Loop: Interplay between Experiments and Predictions Drives PROTACs Bioavailability".
Journal: Journal of medicinal chemistry
Published: July 16, 2025
Closing the Design-Make-Test-Analyze Loop: Interplay between Experiments and Predictions Drives PROTACs Bioavailability.
Journal: Journal of medicinal chemistry
Published: November 08, 2024
Identification of epidermal growth factor receptor-tyrosine kinase inhibitor targeting the VP1 pocket of human rhinovirus.
Journal: Antimicrobial agents and chemotherapy
Published: February 13, 2024
Inhibition of Insulin-Regulated Aminopeptidase by Imidazo [1,5-α]pyridines-Synthesis and Evaluation.
Inhibition of Insulin-Regulated Aminopeptidase by Imidazo [1,5-α]pyridines-Synthesis and Evaluation.
Journal: International journal of molecular sciences
Published: January 23, 2024
All-photonic kinase inhibitors: light-controlled release-and-report inhibition.
Journal: Chemical science
Published: January 17, 2024
Rapid PROTAC Discovery Platform: Nanomole-Scale Array Synthesis and Direct Screening of Reaction Mixtures.
Journal: ACS medicinal chemistry letters
Published: July 31, 2023
Optimization of N-Piperidinyl-Benzimidazolone Derivatives as Potent and Selective Inhibitors of 8-Oxo-Guanine DNA Glycosylase 1.
Journal: ChemMedChem
Published: June 03, 2022
Monitoring drug-target interactions through target engagement-mediated amplification on arrays and in situ.
Journal: Nucleic acids research
Published: March 22, 2022
A high content screening assay for discovery of antimycobacterial compounds based on primary human macrophages infected with virulent Mycobacterium tuberculosis.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: December 03, 2021
Last Updated: 09/26/2026